Cuneo, A. and Foà, R. 2019. RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?. Mediterranean Journal of Hematology and Infectious Diseases. 11, 1 (Feb. 2019), e2019024. DOI:https://doi.org/10.4084/mjhid.2019.024.